Tom Harvey
About Tom Harvey
Tom Harvey is the Senior Vice President, IT, and Chief Information Officer at Alkermes, with over 30 years of experience in IT within the biotechnology, pharmaceutical, and medical device industries.
Current Title and Role
Tom Harvey currently holds the position of Senior Vice President, IT, Chief Information Officer at Alkermes. He assumed this role in February 2018. As the CIO, he is responsible for overseeing the company's information technology strategy, ensuring it aligns with business objectives and regulatory requirements.
Professional Background at Alkermes
Tom Harvey has been with Alkermes since 2005. He started as Director, IT, a position he held for 2 years. He then served as Vice President, IT from 2007 to 2016 for 9 years. Following that, he became Vice President, IT, Chief Information Officer, from 2016 to 2018 for 2 years, before being promoted to his current role. His extensive tenure at Alkermes highlights his long-standing commitment and expertise in managing IT operations and strategy within the company.
Previous Experience at Abbott Laboratories
Before joining Alkermes, Tom Harvey worked at Abbott Laboratories from 1989 to 2004. During his 15 years at Abbott, he held multiple roles, including managing IT for the U.S. Diabetes Care Division. His tenure there also included a 7-year period as Director, IT, at Abbott Diabetes Care and MediSense Products, where he focused on IT strategy and operations for the healthcare sector.
Early Career and Education
Tom Harvey began his career as a Senior Consultant at Deloitte and Touche from 1986 to 1989. He holds a bachelor's degree in Accounting from Virginia Polytechnic Institute and State University, where he studied Accounting with Information Systems. His educational background laid a strong foundation for his career in IT, particularly within the biotechnology, pharmaceutical, and medical device industries.
Skills and Certifications
Tom Harvey is skilled in Digital Strategy, Information Security, Data and Analytics, U.S. Food and Drug Administration (FDA) regulations, Quality Assurance, and Risk and Compliance. He is also Boardroom QTE Certified. His technical expertise and compliance knowledge are complemented by his extensive experience, making him a valuable asset in the fields of biotechnology, pharmaceutical, and medical products.